Cargando…

Angiotensin type-2 (AT-2)-receptor activation reduces renal fibrosis in cyclosporine nephropathy: evidence for blood pressure independent effect

Compound 21 (C21), selective agonist of angiotensin type-2 (AT-2) receptors, shows anti-inflammatory effects in experimental models of hypertension and nephroprotection in diabetes. The aim of the present study was to evaluate the effects of C21 in cyclosporine nephropathy, which is characterized ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Castoldi, Giovanna, di Gioia, Cira R.T., Carletti, Raffaella, Roma, Francesca, Zerbini, Gianpaolo, Stella, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293591/
https://www.ncbi.nlm.nih.gov/pubmed/27679859
http://dx.doi.org/10.1042/BSR20160278
_version_ 1782505109727477760
author Castoldi, Giovanna
di Gioia, Cira R.T.
Carletti, Raffaella
Roma, Francesca
Zerbini, Gianpaolo
Stella, Andrea
author_facet Castoldi, Giovanna
di Gioia, Cira R.T.
Carletti, Raffaella
Roma, Francesca
Zerbini, Gianpaolo
Stella, Andrea
author_sort Castoldi, Giovanna
collection PubMed
description Compound 21 (C21), selective agonist of angiotensin type-2 (AT-2) receptors, shows anti-inflammatory effects in experimental models of hypertension and nephroprotection in diabetes. The aim of the present study was to evaluate the effects of C21 in cyclosporine nephropathy, which is characterized mainly by tubulo-interstitial fibrosis. Ten days before and during the experimental periods, low-salt diet was administered to Sprague–Dawley rats. Cyclosporine-A (CsA; 15 mg/kg per day, intraperitoneal injection) and CsA plus C21 (0.3 mg/kg per day, intraperitoneal injection) were administered for 1 and 4 weeks. Control groups were left without any treatment. Blood pressure (plethysmographic method) and 24 h urinary albumin excretion were measured once a week. At the end of the experimental protocols, the kidneys were excised for histomorphometric analysis of renal fibrosis and for immunohistochemical evaluation of inflammatory infiltrates and type I and type IV collagen expression. After 1 and 4 weeks, the rats treated with CsA showed a significant increase (P<0.01) in blood pressure, no significant changes in urinary albumin excretion and a significant increase (P<0.01) in glomerular and tubulo-interstitial fibrosis and inflammatory infiltrates as compared with the control rats. Treatment with C21 did not modify the CsA dependent increase of blood pressure, which was higher than in control rats, but after 4 weeks of treatment significantly reduced (P<0.01) glomerular and tubulo-interstitial fibrosis, type 1 collagen expression and macrophage infiltration, as compared with rats treated with cyclosporine. The administration of C21 showed a protective effect on cyclosporine nephropathy, decreasing renal fibrosis and macrophage infiltration. These data suggest that C21 may counteract tubulo-interstitial fibrosis, the most potent predictor of the progression of renal diseases.
format Online
Article
Text
id pubmed-5293591
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-52935912017-02-14 Angiotensin type-2 (AT-2)-receptor activation reduces renal fibrosis in cyclosporine nephropathy: evidence for blood pressure independent effect Castoldi, Giovanna di Gioia, Cira R.T. Carletti, Raffaella Roma, Francesca Zerbini, Gianpaolo Stella, Andrea Biosci Rep Original Papers Compound 21 (C21), selective agonist of angiotensin type-2 (AT-2) receptors, shows anti-inflammatory effects in experimental models of hypertension and nephroprotection in diabetes. The aim of the present study was to evaluate the effects of C21 in cyclosporine nephropathy, which is characterized mainly by tubulo-interstitial fibrosis. Ten days before and during the experimental periods, low-salt diet was administered to Sprague–Dawley rats. Cyclosporine-A (CsA; 15 mg/kg per day, intraperitoneal injection) and CsA plus C21 (0.3 mg/kg per day, intraperitoneal injection) were administered for 1 and 4 weeks. Control groups were left without any treatment. Blood pressure (plethysmographic method) and 24 h urinary albumin excretion were measured once a week. At the end of the experimental protocols, the kidneys were excised for histomorphometric analysis of renal fibrosis and for immunohistochemical evaluation of inflammatory infiltrates and type I and type IV collagen expression. After 1 and 4 weeks, the rats treated with CsA showed a significant increase (P<0.01) in blood pressure, no significant changes in urinary albumin excretion and a significant increase (P<0.01) in glomerular and tubulo-interstitial fibrosis and inflammatory infiltrates as compared with the control rats. Treatment with C21 did not modify the CsA dependent increase of blood pressure, which was higher than in control rats, but after 4 weeks of treatment significantly reduced (P<0.01) glomerular and tubulo-interstitial fibrosis, type 1 collagen expression and macrophage infiltration, as compared with rats treated with cyclosporine. The administration of C21 showed a protective effect on cyclosporine nephropathy, decreasing renal fibrosis and macrophage infiltration. These data suggest that C21 may counteract tubulo-interstitial fibrosis, the most potent predictor of the progression of renal diseases. Portland Press Ltd. 2016-11-03 /pmc/articles/PMC5293591/ /pubmed/27679859 http://dx.doi.org/10.1042/BSR20160278 Text en © 2016 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution Licence 4.0 (CC BY) (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Papers
Castoldi, Giovanna
di Gioia, Cira R.T.
Carletti, Raffaella
Roma, Francesca
Zerbini, Gianpaolo
Stella, Andrea
Angiotensin type-2 (AT-2)-receptor activation reduces renal fibrosis in cyclosporine nephropathy: evidence for blood pressure independent effect
title Angiotensin type-2 (AT-2)-receptor activation reduces renal fibrosis in cyclosporine nephropathy: evidence for blood pressure independent effect
title_full Angiotensin type-2 (AT-2)-receptor activation reduces renal fibrosis in cyclosporine nephropathy: evidence for blood pressure independent effect
title_fullStr Angiotensin type-2 (AT-2)-receptor activation reduces renal fibrosis in cyclosporine nephropathy: evidence for blood pressure independent effect
title_full_unstemmed Angiotensin type-2 (AT-2)-receptor activation reduces renal fibrosis in cyclosporine nephropathy: evidence for blood pressure independent effect
title_short Angiotensin type-2 (AT-2)-receptor activation reduces renal fibrosis in cyclosporine nephropathy: evidence for blood pressure independent effect
title_sort angiotensin type-2 (at-2)-receptor activation reduces renal fibrosis in cyclosporine nephropathy: evidence for blood pressure independent effect
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293591/
https://www.ncbi.nlm.nih.gov/pubmed/27679859
http://dx.doi.org/10.1042/BSR20160278
work_keys_str_mv AT castoldigiovanna angiotensintype2at2receptoractivationreducesrenalfibrosisincyclosporinenephropathyevidenceforbloodpressureindependenteffect
AT digioiacirart angiotensintype2at2receptoractivationreducesrenalfibrosisincyclosporinenephropathyevidenceforbloodpressureindependenteffect
AT carlettiraffaella angiotensintype2at2receptoractivationreducesrenalfibrosisincyclosporinenephropathyevidenceforbloodpressureindependenteffect
AT romafrancesca angiotensintype2at2receptoractivationreducesrenalfibrosisincyclosporinenephropathyevidenceforbloodpressureindependenteffect
AT zerbinigianpaolo angiotensintype2at2receptoractivationreducesrenalfibrosisincyclosporinenephropathyevidenceforbloodpressureindependenteffect
AT stellaandrea angiotensintype2at2receptoractivationreducesrenalfibrosisincyclosporinenephropathyevidenceforbloodpressureindependenteffect